184 related articles for article (PubMed ID: 34637062)
21. Comparative study of penetrating keratoplasty and vitreoretinal surgery with Eckardt temporary keratoprosthesis in ocular trauma versus non-trauma patients.
Bové Álvarez M; Arumí CG; Distéfano L; Güell JL; Gris Ó; Mateo C; Corcóstegui B; García-Arumí J
Graefes Arch Clin Exp Ophthalmol; 2019 Nov; 257(11):2547-2558. PubMed ID: 31363832
[TBL] [Abstract][Full Text] [Related]
22. Vitreoretinal surgery in the setting of permanent keratoprosthesis.
Kiang L; Sippel KC; Starr CE; Ciralsky J; Rosenblatt MI; Radcliffe NM; D'Amico DJ; Kiss S
Arch Ophthalmol; 2012 Apr; 130(4):487-92. PubMed ID: 22491917
[TBL] [Abstract][Full Text] [Related]
23. Safety of Concurrent Boston Type I Keratoprosthesis and Glaucoma Drainage Device Implantation.
Lenis TL; Chiu SY; Law SK; Yu F; Aldave AJ
Ophthalmology; 2017 Jan; 124(1):12-19. PubMed ID: 27614591
[TBL] [Abstract][Full Text] [Related]
24. Outcomes of the Boston type 1 and the Aurolab keratoprosthesis in eyes with limbal stem cell deficiency.
Shanbhag SS; Senthil S; Mohamed A; Basu S
Br J Ophthalmol; 2021 Apr; 105(4):473-478. PubMed ID: 32554443
[TBL] [Abstract][Full Text] [Related]
25. Mid-term prognosis of type I Boston keratoprosthesis reimplantation.
Bouhout S; Robert MC; Harissi-Dagher M
Br J Ophthalmol; 2022 Jan; 106(1):37-41. PubMed ID: 33055084
[TBL] [Abstract][Full Text] [Related]
26. Chronic hypotony associated with the Boston type 1 keratoprosthesis.
Dokey A; Ramulu PY; Utine CA; Tzu JH; Eberhart CG; Shan S; Gelhbach PL; Akpek EK
Am J Ophthalmol; 2012 Aug; 154(2):266-271.e1. PubMed ID: 22633347
[TBL] [Abstract][Full Text] [Related]
27. Blood Levels of Tumor Necrosis Factor Alpha and Its Type 2 Receptor Are Elevated in Patients with Boston Type I Keratoprosthesis.
Paschalis EI; Taniguchi EV; Chodosh J; Pasquale LR; Colby K; Dohlman CH; Shen LQ
Curr Eye Res; 2019 Jun; 44(6):599-606. PubMed ID: 30632412
[No Abstract] [Full Text] [Related]
28. The Boston keratoprosthesis in Stevens-Johnson syndrome.
Sayegh RR; Ang LP; Foster CS; Dohlman CH
Am J Ophthalmol; 2008 Mar; 145(3):438-44. PubMed ID: 18207122
[TBL] [Abstract][Full Text] [Related]
29. The Aurolab Keratoprosthesis (KPro) versus the Boston Type I Kpro: 5-year Clinical Outcomes in 134 Cases of Bilateral Corneal Blindness.
Basu S; Serna-Ojeda JC; Senthil S; Pappuru RR; Bagga B; Sangwan V
Am J Ophthalmol; 2019 Sep; 205():175-183. PubMed ID: 30905723
[TBL] [Abstract][Full Text] [Related]
30. Vitreoretinal Complications in Boston Keratoprosthesis Type 1.
Khair D; Salimi A; Harissi-Dagher M
Am J Ophthalmol; 2021 Nov; 231():101-108. PubMed ID: 34107311
[TBL] [Abstract][Full Text] [Related]
31. Clinical Outcomes Using Oversized Back Plates in Type I Boston Keratoprosthesis.
Kaufman AR; Cruzat A; Colby KA
Eye Contact Lens; 2018 Nov; 44(6):399-404. PubMed ID: 29219899
[TBL] [Abstract][Full Text] [Related]
32. Posterior Segment Complications and Impact on Long-Term Visual Outcomes in Eyes With a Type 1 Boston Keratoprosthesis.
Moshiri A; Safi M; Morse LS; Tang VD; Yiu G; Park SS; Schwab I; Li J; Mannis MJ
Cornea; 2019 Sep; 38(9):1111-1116. PubMed ID: 31232746
[TBL] [Abstract][Full Text] [Related]
33. Boston Keratoprosthesis Outcomes in Severe Ocular Chemical Burns in Southern China: A Retrospective Study.
Gu J; Zhai J; Zhou S; Chen J
Adv Ther; 2016 May; 33(5):760-73. PubMed ID: 27126407
[TBL] [Abstract][Full Text] [Related]
34. Intermediate-term Visual Outcomes and Complications of Type 1 Boston Keratoprosthesis With and Without Glaucoma Surgery.
AlHilali S; Martinez-Osorio H; AlObaida I; Jomar D; AlZendi N; AlJassar F; AlShahwan S; Ahmad A; Malik R; Vargas J
Cornea; 2022 Aug; 41(8):950-957. PubMed ID: 35184127
[TBL] [Abstract][Full Text] [Related]
35. Treatment of Oculoplastic and Ocular Surface Disease in Eyes Implanted with a Type I Boston Keratoprosthesis in Southern China: A Retrospective Study.
Zhang Y; Ou Z; Zhou J; Zhai J; Gu J; Chen J
Adv Ther; 2020 Jul; 37(7):3206-3222. PubMed ID: 32436025
[TBL] [Abstract][Full Text] [Related]
36. Boston Type 1 Keratoprosthesis for Iridocorneal Endothelial Syndromes.
Phillips DL; Goins KM; Greiner MA; Alward WL; Kwon YH; Wagoner MD
Cornea; 2015 Nov; 34(11):1383-6. PubMed ID: 26398156
[TBL] [Abstract][Full Text] [Related]
37. Staged ocular fornix reconstruction for glaucoma drainage device under neoconjunctiva at the time of Boston type 1 Keratoprosthesis implantation.
Cortina MS; Karas FI; Bouchard C; Aref AA; Djalilian A; Vajaranant TS
Ocul Surf; 2019 Apr; 17(2):336-340. PubMed ID: 30742989
[TBL] [Abstract][Full Text] [Related]
38. RESULTS OF RETINAL DETACHMENT SURGERY IN EYES WITH OSTEO-KERATOPROSTHESIS.
Vilaplana F; Nadal J; Temprano J; Julio G; Barraquer RI
Retina; 2018 Dec; 38(12):2336-2342. PubMed ID: 28961672
[TBL] [Abstract][Full Text] [Related]
39. Probing mechanisms and improving management of glaucoma following Boston keratoprosthesis surgery.
Geoffrion D; Koenekoop RK; Harissi-Dagher M
Acta Ophthalmol; 2023 Mar; 101(2):242-243. PubMed ID: 36794627
[TBL] [Abstract][Full Text] [Related]
40. Predictive factors of Boston Type I Keratoprosthesis outcomes: A long-term analysis.
Kanu LN; Niparugs M; Nonpassopon M; Karas FI; de la Cruz JM; Cortina MS
Ocul Surf; 2020 Oct; 18(4):613-619. PubMed ID: 32702418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
